Developing Role for Artificial Intelligence in Drug Discovery in Drug Design, Development, and Safety Assessment

Alexander K Hurben; Luke Erber

doi:10.1021/acs.chemrestox.2c00269

Developing Role for Artificial Intelligence in Drug Discovery in Drug Design, Development, and Safety Assessment

Chem Res Toxicol. 2022 Nov 21;35(11):1925-1928. doi: 10.1021/acs.chemrestox.2c00269. Epub 2022 Sep 30.

Authors

Alexander K Hurben¹, Luke Erber¹

Affiliation

¹ Department of Medicinal Chemistry and Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota 55455, United States.

Abstract

Artificial intelligence (AI) is a rapidly growing discipline in the field of chemical toxicology. Herein, we provide a broad overview of research presented at the Fall 2022 American Chemical Society meeting, highlighting how AI is being applied across various facets of drug design, development, and safety assessment.

Publication types

Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural

MeSH terms

Artificial Intelligence*
Drug Design
Drug Discovery*

Abstract

Publication types

MeSH terms

Grants and funding